128 related articles for article (PubMed ID: 37740527)
1. Neoadjuvant chemotherapy for locally advanced colonic cancer is not ready to be the standard of care.
Vimalachandran D
Br J Surg; 2023 Nov; 110(12):1677-1678. PubMed ID: 37740527
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.
Morton D; Seligmann J
Br J Surg; 2023 Nov; 110(12):1679-1680. PubMed ID: 37740517
[No Abstract] [Full Text] [Related]
3. Neoadjuvant chemotherapy for advanced colonic cancer: standard of care or is the jury still out?
Vaughan-Shaw PG; Evans MD
Br J Surg; 2023 Nov; 110(12):1565-1566. PubMed ID: 37724780
[No Abstract] [Full Text] [Related]
4. Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.
Palta M; Czito BG; Willett CG
Nat Rev Clin Oncol; 2014 Apr; 11(4):182-4. PubMed ID: 24642673
[No Abstract] [Full Text] [Related]
5. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
Hong TS; Ryan DP
J Clin Oncol; 2015 Jun; 33(17):1878-80. PubMed ID: 25940719
[No Abstract] [Full Text] [Related]
7. Colorectal cancer.
Maghfoor I
Lancet; 1999 Mar; 353(9157):1013. PubMed ID: 10459936
[No Abstract] [Full Text] [Related]
8. [IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients!].
André T; Taieb J;
Bull Cancer; 2018 Jun; 105(6):546-547. PubMed ID: 29776587
[No Abstract] [Full Text] [Related]
9. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
[No Abstract] [Full Text] [Related]
10. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC).
Hamaguchi T; Shirao K; Moriya Y; Yoshida S; Kodaira S; Ohashi Y;
Cancer Chemother Pharmacol; 2011 Mar; 67(3):587-96. PubMed ID: 20490797
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant and perioperative neoadjuvant therapy for colorectal cancer].
Liu FQ; Cai SJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):315-320. PubMed ID: 31054544
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for colon and rectal cancer.
Fuchs CS; Mayer RJ
Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
[No Abstract] [Full Text] [Related]
13. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
14. Has the time come for implementing neoadjuvant chemotherapy for clinical locally advanced colon cancer?
Bertelsen CA; Kleif J
Colorectal Dis; 2023 Jul; 25(7):1540-1541. PubMed ID: 37165565
[No Abstract] [Full Text] [Related]
15. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy without radiotherapy for patients with locally advanced rectal cancer. Oncologic outcomes.
Cienfuegos JA; Rodríguez J; Baixauli J; Chopitea Ortega A; García-Consuegra A; Abengózar M; Sánchez Justicia C; Hernández Lizoain JL
Rev Esp Enferm Dig; 2020 Jan; 112(1):16-22. PubMed ID: 31729235
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
18. Rectal Cancer: Chemo Matches Radiation.
Cancer Discov; 2023 Aug; 13(8):1753. PubMed ID: 37276326
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
